We use cookies for anonymous analytics (Google Analytics) and ad measurement (Meta Pixel) to improve the site. Neither runs until you agree. Privacy Policy

A hundred stocks ranked by one number. And the number shows its working.

Open the ranking with no sign-up and no card. Click any stock and you get the chart, how risky it is to buy at today's price, what the company's own executives have been buying, and what members of the US Congress disclosed for it.

Free · no sign-up · no card

See it in action

This is all of it.

Real screenshots from the app, not a mock-up. Same thing on a phone — the ranking, the stock pages and the journal all work on the small screen.

stoxeye.app/app
StoxEye ranking — a hundred US stocks with their scores StoxEye stock detail — momentum, support and resistance StoxEye backtest — equity curve against the S&P
StoxEye on a phone StoxEye on a phone

the same thing on a phone

Stock of the week

The highest score right now.

Picked once a week from the same ranking the app runs every half hour — and read the same way the app reads it. It is the top of our list, not a suggestion.

PLTR Palantir Technologies Inc.
$209.05 +5.17% 91

It mostly points up, but the numbers do not sit together — price above the 200-day average pulls one way, insider selling the other.

1-month momentum+26.0% Long-term trendabove the 200-day MA Timeframes lining upperfect bull
Why the signals are strong
Price above the 200-day average
One-month momentum (+26.0%)
What warns against it
Insider selling ($100.8M)
Weak fundamentals (0 of 3 metrics healthy)

Support sits at $184.81 and the price, $209.05, is 11.6% above it. The price has come back to that level once in a year, which is not a floor.

See the whole read in the app →

Built from this stock's own numbers, the same way the app builds it. Not a recommendation to buy or sell anything.

57,600stocks analysed this month
30 minhow often the whole field is recalculated
100US stocks in the ranking, every one of them scored

Pricing

Free is a real plan, not a demo.

Free
$0/ month

The three best-scoring stocks of every scan, with the score and the basic indicators behind them.

  • Top 3 stocks per scan
  • Composite score and the basic indicators
  • News headlines and the macro bar
  • Watchlist of up to 5 stocks
  • The full hundred-stock ranking
  • Alerts, journal, backtesting
Pro
$9.99/ month

All hundred, every panel, and any US stock you can name.

  • All 100 stocks ranked, recalculated every half hour
  • Search and analyse any US stock, not just the hundred
  • Insider desk: Form 4 filings grouped by person, buying clusters, and where the stock ranks against the whole field
  • What members of the US Congress disclosed under the STOCK Act
  • A plain-language read of one stock: what each signal says and whether they agree with each other
  • Entry risk: how far above support today's price sits, scored 0–10
  • Chart with support and resistance, 50+ indicators, macro and options flow
  • Alerts on price, insider buying and buying clusters — plus watchlist, journal, backtesting and CSV export

Annual: $99.99 a year — 17% off. Switch either way whenever you like.

Where the line is

Three things StoxEye will not do.

Inside a stock

What opens when you click a row.

The ranking is the door. Behind it, each stock has its own page — and each panel there answers one question a person actually asks out loud.

Entry risk

Am I buying this too high?

Low, medium or high risk at today's price, with the one number that decides it printed largest: how far above its support the stock is trading right now.

Insider desk

Are the people inside buying?

Every Form 4 filing, grouped by person rather than by filing — one officer unwinding a position files a dozen rows in a day, and ungrouped those read as a dozen sellers. Grants and tax cover are labelled as paperwork, not trades.

Congress

And what about the lawmakers?

What members of the US Congress and their families disclosed for this stock under the STOCK Act. They disclose in brackets, never exact figures, so every amount here is a bracket midpoint and is labelled as an estimate.

The read

Does any of this agree?

A model gets that one stock's data sheet — no other tickers, no house view — and says whether the signals point the same way or contradict each other. It weighs them by what actually predicted returns. It never says buy, sell or hold.

How it works

Thirty seconds, then it's your call.

01

Open the ranking

A hundred stocks sorted by score — seventy percent price movement, thirty percent company quality. No account. If it isn't for you, you're out thirty seconds.

02

Click the one that stands out

Chart, entry risk, insiders, congress, the read — on one page, in the order you'd ask about them.

03

Practise before you pay for it

A demo account to trade on and a journal that asks why you bought. A month later you can read your own reasons back.

The ranking is open. No form in the way.

A hundred stocks, one number each, recalculated every half hour. Look at it once and decide for yourself whether it earns a place in your routine.

Free · no sign-up · no card · not investment advice